‘Dementia link to sudden low blood pressure and dizziness’
October 13, 2024
Precision medicine seeks treatments based on an individual patient’s own physiology and response to diseases
The University of Glasgow has been awarded £3.4m to create a new research centre for precision medicine.
The money will be used to create the largest Medical Research Council (MRC) molecular pathology node in the UK.
Funding has come from the MRC and the Engineering and Physical Sciences Research Council (EPSRC).
Precision medicine seeks treatments based on a patient’s own physiology and response to diseases, rather than a one-size-fits-all approach.
The Glasgow Molecular Pathology Node will integrate laboratory medicine, including pathology and informatics disciplines, which handle and analyse the large datasets that emerge from molecular research.
Prof Anna Dominiczak, head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow, said: “The goal of precision medicine is to provide the right treatment, to the right patient, at the right time, for the right cost and the right outcome.
“We now understand more about abnormalities in DNA and other molecules which occur in disease.
“This so-called ‘molecular pathology’ is revealing significant variation in diseases which by standard classifications, for example by a pathologist using a microscope, have been indistinguishable.
“So, for instance, we now know that pancreatic cancer is not just one disease but many different ones, potentially with different treatments.”
The centre will be based at The Queen Elizabeth University Hospital in Glasgow and will enable scientists, pathologists and clinicians to collaborate with industry partners in developing new diagnostic tests.
Source BBC News